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Abstract
Background: Orf or contagious ecthyma is a zoonotic viral infection with a potential serious health threat for the
small ruminants industry as well as humans. It is currently emerging in new territories.
Results: Eight suspected clinical cases of pustular dermatitis in goats occurred in the rural area of Tebe, in south-
eastern Gabon, in January 2013. The orf virus (ORFV) was detected by high-throughput sequencing on sera, buccal
swabs and scab pool samples. It was confirmed in six out of eight sick goats by using specific PCR targeting the
major envelope protein (B2L) and the orf virus interferon resistance (VIR) genes. Phylogenetic analysis revealed that
the Gabonese strain and South Korean strains evolved from a common ancestor, suggesting an Asian origin of the
ORFV’ Gabonese strain.
Conclusions: This study provides the molecular detection of the ORFV strain involved in the cases of pustular
dermatitis in goats and highlights its circulation in Gabon.
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Background
Orf or contagious ecthyma is a zoonotic viral infection
caused by an enveloped double stranded DNA virus, the
orf virus (ORFV) belonging to the Poxviridae family,
Chordopoxvirinae subfamily, Parapoxvirus genus. This
infectious pustular dermatitis primarily affects sheep,
goats and wild ruminants worldwide [1]. Orf is charac-
terized by proliferative skin lesions of the lips, muzzle,
ears, eyelids, and found around the mouth and nostrils
of lambs [2]. The disease also results in genital, udder
and foot lesions. Additional lesions are observed in the
oral mucosa in severe forms of disease. The transmission
within a herd is carried out through direct contact be-
tween animals during confrontation or suckling. The
morbidity can approach 100 %, whereas the mortality is
usually less than 1 %. Moreover, humans (farmers,
butchers, sheep and goats shearers and veterinarians) can
also be infected by direct contact with sick animals. The
preferential location of the lesions in humans is the hand.
A rash-shaped papule can be seen extending progressively
and forms a pustule in its center. After a few days, the le-
sion evolves and can become very voluminous. The lesion
can present nodules or patches which can be very
oedematous, even vesicular. An associated satellite lymph-
angitis or adenopathy can be observed. Some cases ac-
companied by fever have been described [3].
Consequently, orf has become a potential serious health
threat for the small ruminants industry with an important
economic impact as well as for humans.
The importance of orf infection has recently increased
due to the emergence of this virus in new territories, the
occurrence of re-infection of previously infected animals,
as well as interspecies infection [4]. Several studies seem
to indicate a very high incidence of orf infection (75 %)
during the dry season in the central African region, al-
though actual prevalence is still greatly underestimated
within livestock herds and in humans [4, 5]. In Africa,
orf infection has been reported in sheep and goats only
in a few countries such as Cameroon, Nigeria and
Tanzania [5], on the basis of clinical signs, and in camels
in Kenya, Somalia and Sudan [6–8]. To date on the
African continent, the ORFV was only detected by a
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molecular diagnostic assay from goats and sheep in
Ethiopia, Egypt, and South Africa where the disease is
endemic [9, 10, 11]. In Gabon, no case had yet been re-
corded. In this study, we report the first cases of orf in-
fection causing a small outbreak of pustular dermatitis
in goats in south-eastern Gabon and the molecular
characterization of the viral strain.
Methods
Clinical and epidemiological investigations
In January, in the rural area of Tebe, located in the Prov-
ince of Haut-Ogooué in south-eastern Gabon (Fig. 1a),
eight suspected clinical cases of pustular dermatitis were
reported. Clinical examination of the goats and the sam-
pling process were carried out by a field veterinarian.
Sample collection
Approval was given by the local administrative author-
ities to carry out the sampling and the diagnosis of the
causative agent of the disease observed in the goats of
the Tebe Village. All clinical samples, including plasmas,
sera, as well as buccal and ocular swabs and buccal scabs
were collected from sick animals following the recommen-
dations of the OIE Terrestrial Manual and stored at -80 °C
and sent to the laboratory of the Centre International de
Recherches Médicales de Franceville (CIRMF, Gabon) for
diagnosis.
Serological and virological screening
According to their non-specific nature, these symptoms
can be common to several vesicular diseases of sheep
and goats such as foot and mouth disease and blue-
tongue disease [12], both listed by the World Organisa-
tion for Animal Health as high-impact diseases. The two
viruses causing the aforementioned diseases were ini-
tially searched using specific tools. Indeed, plasmas and
sera were first tested by enzyme-linked immunosorbent
assays (ELISA) to look for the presence of foot and
mouth disease virus (FMDV) and bluetongue virus
(BTV) antibodies as previously described [13, 14]. In
Fig. 1 Geographic location and typical clinical signs of the ORFV infection in goats. Expanded map of Gabon showing the geographic location of
confirmed cases of orf infection among goats, south-eastern Gabon (red circle) (a), proliferative lesions of ORFV infection around the lips and
nostrils of goats (b, c), proliferative lesions on the udders (d)
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parallel, total viral RNA was extracted from all clinical
samples using the EZ1 Virus Mini Kit version 2.0
according to the manufacturer’s instructions, and
BTV [15] and FMDV [16] specific real-time reverse
transcription PCR assays were carried out. Viral iso-
lation was attempted from buccal scabs and sera
using Vero cells.
Molecular characterization of ORFV by high-throughput
sequencing
An approach based on the high-throughput sequencing
of RNA extracted from three selected pools (one pool of
8 sera, one of 6 buccal swabs and the last of 4 buccal
scabs) was performed. RNA was extracted using QIAmp
Viral RNA Minikit (Qiagen), treated with DNAse to re-
move contaminating DNA, and then retro-transcribed
using SuperScript III enzyme and random hexamers
(Invitrogen Inc., Carlsbad, CA). Amplification was done
by using Phi29 enzyme. The Illumina Sequencing using
HiSeq 2000 was conducted with a mean depth per sam-
ple of 20 x 106 single reads of 100 nucleotides (nt) size.
After removal of low-quality reads, a taxonomic assign-
ment was performed by BLASTN against the EMBL
database on each read for each selected pool.
ORFV specific PCR amplifications
In order to confirm the identification of the ORFV as
causative agent of these lesions, an ORFV-specific real-
time PCR assay targeting the B2L gene was performed
on buccal swabs and buccal scabs as previously de-
scribed [17]. Then, two specific conventional PCR tar-
geting the major envelope protein (B2L) and the orf
virus interferon resistance (VIR) genes were performed,
as described previously, on all real-time PCR positive
samples [18].
Phylogenetic analyses
B2L and partial VIR gene sequences of Gabonese ORFV
strains were aligned with homologous sequences of para-
poxvirus reference strains from GenBank, using the
ClustalW algorithm of MEGA program version 5 [19].
Bayesian inference of phylogeny was done using the
MrBayes V.3.2 software and the GTR +G + I nucleotide
substitution model [20] for two million generations with
a burn-in of 25 %.
Results
Several flocks of goats are present in the rural area of
Tebe. Among the herd of about fifty goats on which the
sampling was performed, eight suspected clinical cases
of pustular dermatitis were only reported in this area
during two weeks in January 2013. No mortality was ob-
served. Relevant clinical signs (Table 1) such as buccal
pustules, lip scabs, proliferative and ulcerative lesions on
the nostrils (Fig. 1b and c) and proliferative lesions on
the udders and vulva (Fig. 1d) were observed.
Out of eight sera samples, only two were found posi-
tive for BTV antibodies, and one of the two individuals
was also found positive to FMDV as well (Table 1). Sub-
sequently, specific BTV and FMDV real-time reverse
transcription PCR assays yielded no positive results for
all the clinical samples tested. Moreover, viral isolation
attempted from buccal scabs and sera from six animals
(cases 3, 4, 5, 6, 7 and 8) showed no cytopathic effect.
Sera, buccal swabs and scab pools samples selected for
high-throughput sequencing yielded a total of 376,700,
380,629 and 127,723 reads, respectively, corresponding
to the viral sequences of the ORFV. Both buccal swabs
and buccal scabs were positive for ORFV-specific RT-
PCR. For buccal swabs, Ct values ranged from 24.7 to
37.82. For buccal scabs Ct values were 21.44 and 31.22.
The highest viral load was found in buccal scabs.
Table 1 Clinical data and results of the serological and virological investigations
Id
animal
Sex Clinical signs FMDV BTV ORFV
ELISA qRT-PCR ELISA qRT-PCR B2L PCR VIR PCR
1 F Proliferative lesions around the mouth, pale mucosae, inflammation of
the retro-mandibular lymph nodes, hyperthermia (39,7 °C)
Neg Neg Neg Neg Neg Neg
2 F Abscess at the trough, proliferative lesion around the lips, lacrimation,
conjunctivitis, lymphadenitis poly, hyperthermia (40,5 °C)
Neg Neg Neg Neg Neg Neg
3 F Inflammation of the retro-mandibular lymph nodes, diarrhea, lip scabs,
hyperthermia (39.8 °C)
Neg Neg Pos Neg Neg Pos
4 F Inflammation of the retro-mandibular lymph nodes, proliferative
lesions around the lips and nostrils, hyperthermia (40 °C)
Neg Neg Neg Neg Neg Pos
5 M Ulcerative lesions on the nostrils, hyperthermia (39.9 °C) Neg Neg Neg Neg Pos Pos
6 F Buccal scabs, proliferative lesions in the mouth, on udders and vulva,
hyperthermia (40.3 °C)
Neg Neg Neg Neg Pos Pos
7 F Proliferative lesions on the lips, buccal scabs, hyperthermia (40.1 °C) Pos Neg Pos Neg Neg Pos
8 F Proliferative lesions on the lips and udders, conjunctivitis, lacrimation,
hyperthermia (39.7 °C)
Neg Neg Neg Neg Pos Pos
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Subsequently, the ORFV was detected by specific PCR
in six out of eight goats (Table 1). The sequencing of
amplified PCR products enabled us to obtain two frag-
ments of 546 and 1077 bp for the partial VIR and B2L
genes, respectively.
Based on analysis of the sequences of the B2L gene,
the Gabonese ORFV strain displayed 99 % of identity at
the nucleotide level with the South Korean (JX968992
and GQ328006), Brazilian (JN613810) and Chinese
(JQ904794) strains. As before, analysis of the sequences
of the partial VIR gene indicated that the Gabonese
ORFV strain displayed 97 % of identity at nucleotide
level with the South Korean strains identified in 2009
(GQ328007), 2010 (JX968995) and 2011 (JX968997) and
the Chinese strain (JN565697). Phylogenetic analysis
based on the partial B2L (Fig. 2a) and VIR (Fig. 2b)
genes indicated that the Gabonese strain was closely re-
lated to the Asian strains, especially the South Korean
strains, with which it has evolved from a common an-
cestor (Fig. 2b).
Discussion
We provide, in this study, the first clinical description
and genetic characterization of the orf infection involved
in an outbreak in goats from a rural area in south-
eastern Gabon. No case had been previously recorded in
Gabon in spite of various orf infection already reported
in sheep and goats in other countries of Central Africa
such as Cameroon and Nigeria [5]. However, given the
ubiquitous nature of this virus in small ruminant
populations worldwide (and in proximate regions to
Gabon) and the fact that most infections are subclinical,
it is unlikely this diagnosed case of clinical orf represents
the first appearance of ORFV in Gabon. The compara-
tive sequence analysis revealed that the Gabonese ORFV
strain displayed 99 % of identity at nucleotide level with
the Asian strains, especially the South Korean strains.
These findings would suggest a potential introduction of
this Gabonese ORFV strain from Asian countries, pos-
sibly through their economic activities in Central Africa.
This orf infection does not seem to be the first case of a
virus importation in Africa from Asia. The recent emer-
gence of the Asian “Peste des Petits Ruminants” Virus
lineage IV isolated in Central Africa would be a good ex-
ample of the importation of a virus from this continent
[21]. The presence of the disease in Cameroon could
otherwise have led to an introduction from this neigh-
boring country as had been suggested for the “Peste des
Petits Ruminants” [22]. However, no concrete evidence
to support this hypothesis is available.
In rural areas of Gabon, small ruminants are bred by
straying and frequent contacts between humans and
lambs or kids, which are highly susceptible to orf infec-
tions, could lead to human infection, particularly for
people who butcher these animals. A serological survey
would be needed to assess the level of virus circulation
in animals and humans in order to find out its impact
on livestock, which compose one of the main sources
of animal proteins in villages totally devoid of com-
mercial shops. Thus, a prospective program should be
Fig. 2 Phylogenetic tree based on nucleotide sequences of the B2L gene (a) and VIR gene (b) analysis. The tree was visualized with FigTree 1.3.1.
Bayesian posterior probabilities values are shown to the right of the branches. ORFV sequences obtained in this study are shown in red. In Fig. 2a,
a branch has been shortened and condensed for clarity and represented as dashed branch
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implemented to control, and eradicate in the future,
orf infection in Gabon by vaccinating small ruminants
in order to limit the spread of the disease. Further
molecular and serological analysis could be needed to
better understand the circulation of the ORFV strains
between humans and domestic animals.
In addition to the recent identification of the ORFV in
Gabon, another virus belonging to the Poxviridae family,
the monkeypox virus, has also been identified in Gabon
[23] and in other Central African countries among
which the Central African Republic [24], the Democratic
Republic of the Congo [25] and recently Cameroon
(according to the notification by the Cameroonian
veterinary service at the World Organisation for
Animal Health on July 18th, 2014). The identification
of these two viruses highlight the potential emergence
of poxviruses and the risk of spread of the ORFV in
Central Africa.
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